BRUNO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 13.183
EU - Europa 1.474
AS - Asia 590
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
OC - Oceania 2
AF - Africa 1
Totale 15.262
Nazione #
US - Stati Uniti d'America 13.180
DE - Germania 569
SG - Singapore 323
UA - Ucraina 197
CN - Cina 196
IE - Irlanda 155
IT - Italia 135
RU - Federazione Russa 124
GB - Regno Unito 102
SE - Svezia 71
FI - Finlandia 43
KR - Corea 41
FR - Francia 38
BE - Belgio 14
UZ - Uzbekistan 10
CZ - Repubblica Ceca 8
JP - Giappone 5
NL - Olanda 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
EU - Europa 3
IN - India 3
PL - Polonia 3
SA - Arabia Saudita 3
CA - Canada 2
CH - Svizzera 2
DK - Danimarca 2
HK - Hong Kong 2
IL - Israele 2
IR - Iran 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
CL - Cile 1
DM - Dominica 1
EG - Egitto 1
ES - Italia 1
KG - Kirghizistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
VN - Vietnam 1
Totale 15.262
Città #
Woodbridge 4.157
Wilmington 3.249
Houston 2.870
Ann Arbor 450
Chandler 443
Fairfield 354
Singapore 292
Ashburn 179
Jacksonville 178
Dublin 153
Dearborn 115
Seattle 114
Cambridge 110
Medford 109
New York 93
Beijing 72
Santa Clara 68
Zhengzhou 52
Lawrence 50
Rome 48
Munich 23
San Diego 19
Hefei 15
Moscow 15
Brussels 14
Mülheim 14
Milan 13
Nanjing 11
Norwalk 11
Palo Alto 11
University Park 11
Boardman 10
London 9
Menlo Park 9
Brno 8
Colorado Springs 7
Creede 7
Mountain View 7
Shanghai 7
Center 6
Chicago 6
Kunming 6
Nürnberg 6
Los Angeles 5
Nuremberg 5
Redwood City 5
Verona 5
Falls Church 4
Hebei 4
Helsinki 4
Hounslow 4
Inverigo 4
Nanchang 4
Paris 4
Seoul 4
Arosio 3
Detroit 3
Guangzhou 3
Indiana 3
Redmond 3
San Francisco 3
Ypsilanti 3
Bologna 2
Chiswick 2
Deiva Marina 2
Del Norte 2
Fuzhou 2
Hong Kong 2
Jinan 2
Kissimmee 2
Leawood 2
Lima 2
New Bedfont 2
Qazvin 2
Quzhou 2
Riyadh 2
Simi Valley 2
Striano 2
Trieste 2
Turin 2
Venice 2
Ürümqi 2
Almere Stad 1
Amsterdam 1
Auburn Hills 1
Auckland 1
Augusta 1
Beograd 1
Berlin 1
Bishkek 1
Burlingame 1
Changsha 1
Chengdu 1
Chions 1
Clifton 1
Corona 1
Council Bluffs 1
Den Haag 1
Dubai 1
Espoo 1
Totale 13.532
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 461
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 452
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 451
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 438
CD7 expression in acute myeloid leukemia 437
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 432
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 428
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 428
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 426
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 424
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 424
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 417
Biological features of acute myeloid leukemia in the elderly 415
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 410
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 406
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 405
Diagnosis of acute myeloid leukemia and system Coulter VCS 404
AML-M0: a biological and clinical profile 402
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 391
Biological pattern of AML-M0 versus AML-M1: Response 386
Evaluation of biological features of cord blood units collected with different methods after cesarean section 385
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 384
P-glycoprotein expression in de novo acute myeloid leukemia 381
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 380
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 377
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 370
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 362
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 360
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 360
Lineage identification of acute leukemias: relevance of immunological and ultrastruttural techniques 346
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 336
Prognostic value of cell marker analysis in de-novo acute myeloid-leukemia 318
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 316
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia 309
Apoptosis and immaturity in acute myeloid leukemia 296
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 286
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 281
Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 145
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 95
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 90
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 88
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 84
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 70
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 68
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 63
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 52
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab 50
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 45
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 45
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation 38
Theoretical and therapeutic implications of the spasticity-plus syndrome model in multiple sclerosis 38
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 32
Osteopontin Is Associated with Multiple Sclerosis Relapses 31
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 27
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 24
Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery? 16
Totale 15.385
Categoria #
all - tutte 32.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.364 0 0 0 0 313 411 334 296 271 287 194 258
2020/20212.065 220 241 201 283 178 187 349 198 72 30 87 19
2021/2022579 15 57 5 48 10 85 24 24 50 59 31 171
2022/2023947 91 84 85 114 68 212 81 47 92 15 39 19
2023/2024312 44 7 12 2 31 117 10 1 2 3 24 59
2024/2025644 42 345 175 55 27 0 0 0 0 0 0 0
Totale 15.385